Sinus of Valsalva aneurysm rupture is a rare condition with a great potential for morbidity and mortality if not promptly diagnosed and managed. We present an unusual non-infected sinus of Valsalva aneurysm rupture in a 47-year-old female. This case report, a likely presentation of a late congenital heart defect, highlights the need for a high index of suspicion in a patient with atypical history of congestive cardiac failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0267659120966915 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Rare Case of Ruptured Sinus of Valsalva Aneurysm With Noncoronary Sinus to the Right Ventricle.
Ann Thorac Surg Short Rep
September 2024
Department of Cardiovascular Surgery, JCHO Kyushu Hospital, Kitakyushu City, Japan.
Similar size formula for annulus, leaflet, and valsalva sinus in valve-sparing operations during bicuspid aortic valve repair.
JTCVS Open
December 2024
Department of Cardiac Surgery, Faculty of Medicine, Institute of Heart Diseases Clinical, Wroclaw Medical University, Wroclaw, Poland.
Rare Coronary Artery Anomaly: Single Coronary Artery from Distal Circumflex Detected by CT.
Am J Case Rep
January 2025
Department of Cardiology, Centre Hospitalier François Mitterrand de Pau (CHPAU), Pau, France.
BACKGROUND A single coronary artery is a rare congenital anomaly of the coronary arteries distribution, with an incidence of only 0.03% in the general population undergoing coronary angiography. RCA arising from the distal circumflex artery is an extremely rare variety.
View Article and Find Full Text PDFTrans-Coronary Sinus Intra-Septal Radiofrequency Ablation (TIRA) for Hypertrophic Obstructive Cardiomyopathy: First-in-Human Results.
Biomedicines
December 2024
Department of Internal Medicine, Pusan National University School of Medicine and Cardiology, Cardiovascular Center and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
Background: Current treatments for hypertrophic obstructive cardiomyopathy (HOCM), including medication, surgery, and alcohol septal ablation (ASA), have limitations in terms of efficacy and safety. To address these challenges, we developed the trans-coronary intra-septal radiofrequency ablation (TIRA) device.
Methods: This first-in-human trial was conducted to assess the efficacy and safety of the TIRA device.
A "bulb" in the heart: a rupture of the non-coronary Valsalva sinus aneurysm into the atrial septum.
Eur Heart J Cardiovasc Imaging
January 2025
Department of Ultrasound, Nanchong Central Hospital, Nanchong, Sichuan Province, People's Republic of China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!